Optometrists in Fort Leonard Wood, MO Accepting Medicare

11 Optometrists found. Showing 1 - 11

Ettinger Optometry, Llc Optometrist - Corneal and Contact Management Medicare: Medicare Enrolled Practice Location: 143 Replacement Ave, Building 487, Fort Leonard Wood, MO 65473 Phone: 573-329-4860    Fax: 573-329-4860

Peyton Mckay Simpson, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-0048

Shriya Ruparel Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-0048

Amy Molina, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-0048    Fax: 573-596-0716

Sunland Optical Co., Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 143 Replacement Ave, Bld 487, Fort Leonard Wood, MO 65473 Phone: 573-329-4860

Dr. Nathan D Dederman, OD, FAAO Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4430 Missouri Ave # 1267, Fort Leonard Wood, MO 65473 Phone: 505-249-9251

Jessica Ward, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-0035

Andrew Brown, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 870-634-6294

Jon-erik Kampwerth Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-0048

Haley & Assoc, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 143 Replacement Ave, Bldg 487, Fort Leonard Wood, MO 65473 Phone: 573-329-4860    Fax: 573-329-4864

Dr. Benjamin Matlack Swede, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 126 Missouri Ave, Mcxp-ccs-cr, Fort Leonard Wood, MO 65473 Phone: 573-596-0417    Fax: 573-596-0524

News Archive

Gilead's Quad Phase 3 clinical study in treatment-naïve HIV-1 patients meets 48-week primary objective

Gilead Sciences, Inc. today announced that the second pivotal Phase 3 clinical trial of its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, being evaluated for HIV-1 infection in treatment-naïve patients, met its primary objective of non-inferiority at week 48 as compared to ritonavir-boosted atazanavir plus Truvada.

2015 Frost & Sullivan Asia Pacific CRO Company of the Year award goes to Quintiles

Quintiles has clinched the 2015 Frost & Sullivan Asia Pacific Contract Research Organization (CRO) Company of the Year award. Frost & Sullivan selected Quintiles based on its in-depth evaluation of CRO companies' performance in the current Asia Pacific market landscape and its emerging trends.

Study sheds light on several aspects of Ebola virus flare-ups in Liberia

Ebola virus samples taken from patients in Liberia in June 2015 are strikingly similar in their genetic makeup to other Ebola virus sequences from Western Africa, according to research published online today in the journal Science Advances. The study sheds light on several aspects of the "flare-ups" that have occurred in Liberia since the country was initially declared free of Ebola virus disease.

ICF International awarded re-compete contract to provide IT, scientific support services to NCTR

ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a $31.8 million re-compete contract by the U.S. Food and Drug Administration to provide information technology and scientific support services to the National Center for Toxicological Research.

SkyePharma delivery technologies for respiratory drugs to feature at two international conferences

SkyePharma PLC has announced that its proprietary delivery technologies for respiratory drugs will be presented later this month at two international conferences, one in the UK and one in America.

Read more Medical News

› Verified 3 days ago